Artesunate Amivas is a malaria medicine used as initial treatment of severe malaria in adults and children. Malaria is an infection caused by a parasite known as Plasmodium. ‘Severe’ malaria means the disease involves potentially life-threatening symptoms. Malaria is rare in the EU, and Artesunate Amivas was designated an ‘orphan medicine’ (a medicine used in rare diseases) on 28 February 2020. Artesunate Amivas contains the active substance artesunate.
Therapeutic Indication
### Therapeutic indication Artesunate Amivas is indicated for the initial treatment of severe malaria in adults and children. Consideration should be given to official guidance on the appropriate use of antimalarial agents.
Therapeutic Area (MeSH)
ATC Code
P01BE03
ATC Item
artesunate
Pharmacotherapeutic Group
Antiprotozoals
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| artesunate | N/A | 青蒿琥酯 |
EMA Name
Artesunate Amivas
Medicine Name
Artesunate Amivas
Aliases
N/A
